ATE243206T1 - Alpha-substituierte 3-benzyl-benzofurane - Google Patents
Alpha-substituierte 3-benzyl-benzofuraneInfo
- Publication number
- ATE243206T1 ATE243206T1 AT96301538T AT96301538T ATE243206T1 AT E243206 T1 ATE243206 T1 AT E243206T1 AT 96301538 T AT96301538 T AT 96301538T AT 96301538 T AT96301538 T AT 96301538T AT E243206 T1 ATE243206 T1 AT E243206T1
- Authority
- AT
- Austria
- Prior art keywords
- benzyl
- alpha
- substituted
- present
- benzofuranes
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- BVQFHAIYRRWINS-UHFFFAOYSA-N 3-benzyl-1-benzofuran Chemical class C=1OC2=CC=CC=C2C=1CC1=CC=CC=C1 BVQFHAIYRRWINS-UHFFFAOYSA-N 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 206010027304 Menopausal symptoms Diseases 0.000 abstract 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 abstract 1
- 208000002495 Uterine Neoplasms Diseases 0.000 abstract 1
- 210000003679 cervix uteri Anatomy 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940011871 estrogen Drugs 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 1
- 125000001033 ether group Chemical group 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003568 thioethers Chemical group 0.000 abstract 1
- 206010046766 uterine cancer Diseases 0.000 abstract 1
- 210000004291 uterus Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S206/00—Special receptacle or package
- Y10S206/828—Medicinal content
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/402,414 US5622974A (en) | 1995-03-10 | 1995-03-10 | α-substituted-3-benzyl-benzofurans |
| US08/536,313 US5705507A (en) | 1995-03-10 | 1995-09-29 | Aplha-substituted-3-benzyl-benzofurans |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE243206T1 true ATE243206T1 (de) | 2003-07-15 |
Family
ID=27017869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96301538T ATE243206T1 (de) | 1995-03-10 | 1996-03-06 | Alpha-substituierte 3-benzyl-benzofurane |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5705507A (de) |
| EP (1) | EP0731098B1 (de) |
| JP (1) | JPH08283254A (de) |
| AT (1) | ATE243206T1 (de) |
| CA (1) | CA2171399A1 (de) |
| DE (1) | DE69628688T2 (de) |
| ES (1) | ES2201151T3 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2218756A1 (en) * | 1996-10-25 | 1998-04-25 | Kristin Sue Marron | Substituted benzo¢b!thiophene compounds having activity as selective estrogen receptor modulators |
| GB9624800D0 (en) * | 1996-11-29 | 1997-01-15 | Lilly Co Eli | Methods of preventing breast cancer |
| US6317795B1 (en) * | 1997-07-22 | 2001-11-13 | International Business Machines Corporation | Dynamic modification of multimedia content |
| US6127419A (en) * | 1998-11-23 | 2000-10-03 | Burzynski; Stanislaw R. | Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis |
| US6774248B2 (en) * | 2001-12-18 | 2004-08-10 | Wyeth | Substituted 2-phenyl benzofurans as estrogenic agents |
| US7833322B2 (en) * | 2006-02-28 | 2010-11-16 | Sharper Image Acquisition Llc | Air treatment apparatus having a voltage control device responsive to current sensing |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
| US4380635A (en) * | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
| US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
| US4806663A (en) * | 1987-04-06 | 1989-02-21 | The University Of Tennessee Research Corporation | Certain 3-substituted 2-alkyl benzofuran derivatives |
| US4851554A (en) * | 1987-04-06 | 1989-07-25 | University Of Tennessee Research Corporation | Certain 3-substituted 2-alkyl benzofuran derivatives |
| TW366342B (en) * | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
| US5354861A (en) * | 1992-11-04 | 1994-10-11 | National University Of Singapore | 2-(benzyl)-3-arylbenzofurans as antitumour and hypocholesterolemic agents |
| US5482949A (en) * | 1993-03-19 | 1996-01-09 | Eli Lilly And Company | Sulfonate derivatives of 3-aroylbenzo[b]thiophenes |
| US6756388B1 (en) * | 1993-10-12 | 2004-06-29 | Pfizer Inc. | Benzothiophenes and related compounds as estrogen agonists |
-
1995
- 1995-09-29 US US08/536,313 patent/US5705507A/en not_active Expired - Fee Related
-
1996
- 1996-03-06 DE DE69628688T patent/DE69628688T2/de not_active Expired - Fee Related
- 1996-03-06 AT AT96301538T patent/ATE243206T1/de not_active IP Right Cessation
- 1996-03-06 EP EP96301538A patent/EP0731098B1/de not_active Expired - Lifetime
- 1996-03-06 ES ES96301538T patent/ES2201151T3/es not_active Expired - Lifetime
- 1996-03-08 CA CA002171399A patent/CA2171399A1/en not_active Abandoned
- 1996-03-11 JP JP8053376A patent/JPH08283254A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP0731098A1 (de) | 1996-09-11 |
| EP0731098B1 (de) | 2003-06-18 |
| CA2171399A1 (en) | 1996-09-11 |
| JPH08283254A (ja) | 1996-10-29 |
| US5705507A (en) | 1998-01-06 |
| DE69628688T2 (de) | 2004-04-08 |
| ES2201151T3 (es) | 2004-03-16 |
| DE69628688D1 (de) | 2003-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0309355A (pt) | 2-(2,6-diclorofenil)-diarilimidazóis | |
| EA200100524A1 (ru) | Амиды антраниловой кислоты и их применение в качестве лекарственных средств | |
| NZ527123A (en) | Oxazolyl-pyrazole derivatives as kinase inhibitors | |
| DE69713526D1 (de) | Lösliche prodrugs von paclitaxel | |
| DE69912606D1 (de) | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivate | |
| CY1107815T1 (el) | 1,3 - διϋποκατεστημεναι και 1,3,3 -τριϋποκατεστημεναι πυρρολιδιναι ως συνδεσμικα μεσα υποδοχεως ισταμινης -3, και θεραπευτικαι εφαρμογαι των | |
| EP1353672A4 (de) | Synthese von 3-aminothalidomid und seinen enantiomeren | |
| BR9401183A (pt) | Composto e formulação farmacêutica | |
| GB0225475D0 (en) | Therapeutic agents | |
| NZ516347A (en) | Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them | |
| HN1999000124A (es) | Derivados de pirazol substituido. | |
| BR0113234A (pt) | Polimorfos de um análogo de epotilona | |
| BRPI0408990A (pt) | derivados de pirimidin-4-ona e sua utilização como moduladores da p38-cinase | |
| EA200001223A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
| ES2134560T3 (es) | 1-bencil-naftilos alfa-sustituidos. | |
| SE8704248D0 (sv) | Medical use | |
| ATE272629T1 (de) | Benzothiophene | |
| NO20014241D0 (no) | C16-umettede FP-selektive prostaglandinanaloger | |
| ATE243206T1 (de) | Alpha-substituierte 3-benzyl-benzofurane | |
| ATE242773T1 (de) | 3-benzyl-benzothiophene | |
| DK418986D0 (da) | Pyrrolobenzimidazoler, pyrrolobenzoxazoler og pyrrolobenzthiazoler, fremgangsmaader til fremstilling heraf og laegemidler med indhold heraf | |
| EP0902025A3 (de) | Benzothiophene zur Behandlung von Estrogen-abhängigen Erkrankungen | |
| ES2181004T3 (es) | Composicion farmaceutica que contiene un extracto embrionario como sustancia activa y procedimiento de preparacion relativo. | |
| AU6826700A (en) | Ceramide analogs, process for their preparation and their use as antitumor agents | |
| ATE263164T1 (de) | Bentzothiophene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |